Highbridge Capital Management LLC Abb Vie Inc. Call Options Transaction History

Highbridge Capital Management LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $284,512 - $316,288	-3,200 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $1.54 Million - $1.82 Million	-17,100 Reduced 84.24%	3,200 $296,000
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $797,084 - $874,069	8,900 Added 78.07%	20,300 $1.96 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $796,289 - $1.02 Million	11,400	11,400 $1.01 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.